NCT06696300 Effects of Foundation and Functional Inspiratory Muscle Training in Non-Specific Chronic Low Back Pain
| NCT ID | NCT06696300 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kirsehir Ahi Evran Universitesi |
| Condition | Low Back Pain, Mechanical |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-12-15 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-12-15 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study was planned to examine the effects of basic and functional respiratory muscle training on pain, disability level, and functionality. In this study, participants will be randomly divided into 3 groups. The first group will be treated with physical therapy applications applied in state hospitals for 10 weeks. The second group will receive basic respiratory muscle training treatment in addition to physical therapy in state hospitals. The third group will receive respiratory muscle training with exercise in addition to physical therapy in state hospitals. Evaluations will be made before the first session, after the 30th session, in the 3rd month, in the 6th month, and in the 1st year. There is no interventional method in the evaluations. Pain intensity, disability level, physical activity status, quality of life, fear of movement, pain catastrophizing, anxiety and depression levels will be questioned with scales. In physical measurements, participant's aerobic capacity will be measured with the 2-Minute Walk Test, participants's flexibility with the sit-and-long test, participants's respiratory muscle strength with the MIP/MEP device, participants's core endurance with the trunk flexor muscle endurance test, participants's lower and upper extremity muscle strength with a handheld dynamometer, participants's postural control with the Biodex balance device, and participants's muscle thickness with an ultrasound.
Eligibility Criteria
Inclusion Criteria: * Volunteering to participate in the study, * Being between the ages of 18-65, * Having low back pain that has been ongoing for at least 3 months (12 weeks), * Having a Visual Analog Scale (VAS) of pain intensity of ≥3, * Being right-hand dominant. Exclusion Criteria: * Not volunteering to participate in the study, * Having a history of cancer, * Having a spinal infection, * Having a rheumatological condition, * Having a spinal fracture, * Having red flag signs (sudden and unexpected weight loss, fever, etc.) * Having a psychological disorder, * Having a previous spinal surgery, * Having radiculopathy (neuropathic pain along the lower extremity due to nerve root compression), * Not continuing home exercises more than 80%, * Having an anatomical and congenital abnormality
Contact & Investigator
Türkan Akbayrak, Professor
STUDY DIRECTOR
Hacettepe University
Frequently Asked Questions
Who can join the NCT06696300 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Low Back Pain, Mechanical. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06696300 currently recruiting?
Yes, NCT06696300 is actively recruiting participants. Contact the research team at fatih.ozyurt10@gmail.com for enrollment information.
Where is the NCT06696300 trial being conducted?
This trial is being conducted at Kırşehir, Turkey (Türkiye).
Who is sponsoring the NCT06696300 clinical trial?
NCT06696300 is sponsored by Kirsehir Ahi Evran Universitesi. The principal investigator is Türkan Akbayrak, Professor at Hacettepe University. The trial plans to enroll 60 participants.